Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
B
Baha’a Jabali
Researcher
Also affiliated: Birzeit University (2016)
Unknown Researcher
4 h-index
5 pubs
110 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Baha’a Jabali's research focuses on the discovery and development of novel kinase inhibitors for cancer treatment. His work involves studying the structure-activity relationships of small molecules to identify potent and selective drug candidates. Jabali has investigated compounds targeting aurora kinase B, leading to the identification of an orally active selective inhibitor. He has also explored derivatives of pyrimido[4,5-b]indole as dual RET/TRKA inhibitors. His recent publications include a perspective on macrocyclic kinase inhibitors and the discovery of new selective inhibitors. Jabali collaborates with researchers at the University of Arkansas for Medical Sciences, including Brendan Frett, Baku Acharya, and Maha Hanafi.
Metrics
- h-index: 4
- Publications: 5
- Citations: 110
Selected Publications
-
Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor (2025)
-
Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors (2024)
-
Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules (2023)
Collaboration Network
Top Collaborators
Brendan Frett
University of Arkansas for Medical Sciences
3 shared publications
In database
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor
- Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors
Baku Acharya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors
Debasmita Saha
Discovery Institute (US)
2 shared publications
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors
Daniel W. Armstrong
University of Arkansas for Medical Sciences
2 shared publications
In database
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors
Maha Hanafi
Cairo University
2 shared publications
In database
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
- Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors
Alan Herrera-Rueda
University of Arkansas for Medical Sciences
1 shared publication
In database
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
Naga Rajiv Lakkaniga
Indian Institute of Technology Dhanbad (IN)
1 shared publication
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules
Noemi Garcia Garcia
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors
Katie R. Ryan
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors
Phuc Tran
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor
Marialuisa Moccia
University of Naples Federico II (IT)
1 shared publication
- Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor
Xiuqi Wang
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor
Annalisa Brescia
University of Naples Federico II (IT)
1 shared publication
- Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor
Giorgia Federico
University of Naples Federico II (IT)
1 shared publication
- Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor
Gunaganti Naresh
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor
Similar Researchers
Based on overlapping research topics
Phuc Tran
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Structure-Activity Relationship
Drug Discovery
Anupreet Kharbanda
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Structure-Activity Relationship
Drug Discovery
Brendan Frett
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Structure-Activity Relationship
Protein Kinase Inhibitors
Yuntao Dai
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Cancer-related molecular mechanisms research
Fabricio Medina‐ Bolivar
Arkansas State University
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Cancer-related molecular mechanisms research
Katie R. Ryan
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Protein Kinase Inhibitors
Molecular Biology Techniques and Applications